Hepatitis B Market size was valued at USD 5.1 Billion in 2023 and the total Hepatitis B Revenue is expected to grow at a CAGR of 4.2 % from 2024 to 2030, reaching nearly USD 6.80 Billion in 2030.
Hepatitis B Market Overview:
This study categorizes the Hepatitis B Market market to anticipate revenues and analyze trends in each of the sub-markets listed below.
Market Scope:
The competition strategic window researches the competitive environment in terms of markets, applications, and regions to assist the vendor in defining an alignment or fit between their strengths and future growth opportunities.It describes the optimum or most beneficial fit for vendors to pursue sequential merger and acquisition tactics, regional expansion, R&D, and new product launch techniques to execute future business expansion and growth over a projected period.
Details insights on this market, request for methodology here@https://www.maximizemarketresearch.com/request-sample/187847
Segmentation:
by Therapy
Chemo Therapy
Immunosuppressant Therapy
Nucleoside Analogue
by Product Type
Hepatitis B Vaccine
Anti-viral Drugs
Tenofovir
Entecavir
by End User Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Players:
1. Gilead Sciences - USA - Antiviral medications
2. Bristol-Myers Squibb - USA - Antiviral medications
3. AbbVie - USA - Antiviral medications
4. Abbott Laboratories - USA - Diagnostic tests
5. Thermo Fisher Scientific - USA - Diagnostic tests
6. Becton, Dickinson and Company - USA - Diagnostic tests
7. Johnson & Johnson - USA - Diagnostic tests
8. Dynavax Technologies Corporation - USA - Vaccines
9. MedImmune - USA – Vaccines
10. GlaxoSmithKline - UK - Vaccines
11. Merck & Co. Inc. - USA – Vaccines
12. Pfizer Inc. - USA - Vaccines
13. Novartis AG - Switzerland - Antiviral medications
14. Siemens Healthineers - Germany - Diagnostic tests
15. Roche - Switzerland - Diagnostic tests
16. Sanofi Pasteur - France - Vaccines
17. Qiagen N.V. - Netherlands - Diagnostic tests
18. F. Hoffmann-La Roche AG - Switzerland - Antiviral medications
19. Astellas Pharma - Japan - Antiviral medications
20. GeneOne Life Science Inc. - South Korea - Vaccines
21. Hualan Biological Engineering Inc. - China - Vaccines
22. Mitsubishi Tanabe Pharma - Japan - Antiviral medications
23. Serum Institute of India - India - Vaccines
24. Zydus Cadila - India - Vaccines
25. Beijing Tiantan Biological Products Co., Ltd. - China – Vaccines
26. Bio-Manguinhos – Brazil – Vaccines
27. Saudi Biological Industries – Saudi Arabia - Vaccines
Regional Analysis:
The Hepatitis B Market market prediction research is created after a thorough examination of many geographical areas, including Asia-Pacific, Europe, North America, and the rest of the globe. North America has the greatest power over the Hepatitis B Market market share and will continue to be a major shareholder in the global Hepatitis B Market market.
COVID-19 Impact Analysis on Hepatitis B Market Market:
The impact of COVID-19 pandemic on Hepatitis B Market market has also been included in the report.
please contact us:https://www.maximizemarketresearch.com/market-report/hepatitis-b-market/187847/
Key Questions Answered in the Hepatitis B Market Market Report are:
- Which are the prominent players in the Hepatitis B Market market?
- What key trends are likely to emerge in the Hepatitis B Market market in the coming years?
- What will be the Hepatitis B Market market size by 2030?
- Which company held the largest share in the Hepatitis B Market market?
About us
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
